Article
Neuropeptide Y Leu7Pro polymorphism associated with the metabolic syndrome and its features in patients with coronary artery disease.
Angiology - 1 Jan 2013
Masoudi-Kazemabad Ali, Jamialahmadi Khadijeh, Moohebati Mohsen, Mojarrad Majid, Manshadi Raheleh Dehghan, Akhlaghi Saeed, Ferns Gordon A, Ghayour-Mobarhan Majid
Abstract excerpt
The metabolic syndrome (MetS) is characterized by constellation of clinical and biochemical features that increase the risk of cardiovascular disease. Neuropeptide Y (NPY) is a neurotransmitter and enhances the development of obesity and other aspects of MetS. We determined the association between NPY Leu7Pro polymorphism and features of MetS in Iranian patients with coronary artery disease (CAD). A total of 550...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
